Home / Business and Economy / Bath & Body Works Hits 25th 52-Week Low as Stock Plummets 75% from Peak
Bath & Body Works Hits 25th 52-Week Low as Stock Plummets 75% from Peak
14 Nov, 2025
Summary
- Bath & Body Works stock hits 25th 52-week low in past year
- Stock trades at just 25% of its November 2021 all-time high of $82
- Retailer's sales and profits surged during COVID, but have since declined
As of November 14, 2025, Bath & Body Works, a specialty retailer known for its body care products and home fragrances, has hit its 25th 52-week low in the past year. The company's stock, which soared to a 20-year high of $82 in November 2021 during the COVID-19 pandemic, now trades at just one-quarter of that value.
The dramatic decline in Bath & Body Works' stock price reflects the company's changing fortunes. During the pandemic, the retailer experienced a surge in sales and profits, with its 2021 revenue reaching $7.88 billion, up 23% and 46% from 2020 and 2019, respectively. However, as the effects of the pandemic have waned, the company's performance has faltered, leading to the stock's precipitous drop.
Investors are now left to debate whether Bath & Body Works' current valuation represents a bargain opportunity or a risky bet. On one hand, the stock's steep decline from its recent highs could attract value-oriented investors. On the other hand, the company's ongoing struggles may indicate deeper underlying issues that could continue to weigh on the stock's performance.
